Bioxcel Therapeutics's total assets for Q1 2026 were $34.02M, a decrease of -24.25% from the previous quarter. BTAI total liabilities were $139.57M for the fiscal quarter, a -0.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.